Effects of Crossover Point Exercise on Vascular Function of Women in Different Menopausal Years
NCT ID: NCT06201312
Last Updated: 2024-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2023-12-11
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All participates will undergo a graded exercise test to determine their maximum oxygen uptake, and vascular function response will be measured immediately after the exercise test. The COP exercise intensity for postmenopausal women will be obtained through the exercise test, and subjects in the EE and LE groups will undergo exercise training at this intensity for a period of three months. Tests and analyses of relevant indicators will be conducted on subjects in all four groups before and after the intervention. The exercise load experiments will be performed on a cycle ergometer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Different Exercise Modalities on Cardiovascular and Cognitive Response in Postmenopausal Women
NCT06533982
Effects of COP Exercise and HIIT on Vascular Health in Young Overweight Females
NCT05817487
Effects of Crossover Point Exercise on Depression, Anxiety and Stress in Chinese Postmenopausal Women
NCT06449807
The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women
NCT03752060
Building Strength for Menopause
NCT06813404
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Postmenopausal Exercise Group (EE)
COP exercise
crossover point intensity exercise
Late Postmenopausal Exercise Group (LE)
COP exercise
crossover point intensity exercise
Early Postmenopausal Control Group (EC)
No interventions assigned to this group
Late Postmenopausal Control Group (LC)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COP exercise
crossover point intensity exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* BMI \<18.5 kg/m2 or BMI \>28 kg/m2
* fasting plasma triglyceride levels ≥500 mgdl
* diabetes mellitus or fasting glucose \>140 mgd
* blood creatinine \>2.0 mgdl
* uncontrolled hypertension (systolic blood pressure \>160 mmHg and/or diastolic blood pressure \>110 mmHg)
* untreated thyroid disease
* life-threatening illness with a prognosis of \<5 years;
* history of deep vein thrombosis,
* pulmonary embolism, or breast cancer;
* currently receiving estrogen therapy.
45 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Sport University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Sports Medicine and Rehabilitation, Beijing Sport University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EOCPEOVFOWIDMY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.